Skip to content

Clinical trials

Observational Glioblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Observational Clear all

210 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20031
20044
20052
20066
20075
20084
20096
20102
20114
20124
20136
20148
20157
201613
201712
201815
20199
20206
202114
202213
202320
202420
202512
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81
Recruiting39
Unknown status34
Terminated18
Not yet recruiting15
Active, not recruiting10
Withdrawn8
Suspended3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University5
National Cancer Institute (NCI)5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5
Jasper Gerritsen4
Juan M Garcia-Gomez4
Maastricht Radiation Oncology4
Erasmus Medical Center3
Hospital del Rio Hortega3
Merck Sharp & Dohme LLC3
National Institute of Neurological Disorders and Stroke (NINDS)3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma210
Glioma65
Astrocytoma41
Brain Neoplasms41
Oligodendroglioma18
Neoplasms16
Gliosarcoma14
Central Nervous System Neoplasms13
Breast Neoplasms9
Ependymoma8

Trials

Showing 51 to 75 of 210. Each trial links to its page on Pharma Observatory.

110 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.